Evidence map›Paper›PMID 25881240›Full record

SynthesisBMC psychiatry2015

Health service use and costs associated with aggressiveness or agitation and containment in adult psychiatric care: a systematic review of the evidence.

Maria Rubio-Valera, Juan V Luciano, José Miguel Ortiz, Luis Salvador-Carulla, Alfredo Gracia, Antoni Serrano-Blanco

Registry-linked trialAbstract readSystematic Review
In one paragraph

Synthesis in BMC psychiatry, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06093451 (An Open-Label, Randomized, Active Controlled Inpatient Trial Evaluating Sublingual Dexmedetomidine For Moderate To Severe Agitation In Inpatients With Schizophrenia Or Bipolar Disorder), which is not on this map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06093451 phase4unknown statusnot on this mapstarted 2023, after this paper: background citation

An Open-Label, Randomized, Active Controlled Inpatient Trial Evaluating Sublingual Dexmedetomidine For Moderate To Severe Agitation In Inpatients With Schizophrenia Or Bipolar Disorder

TypeinterventionalSponsorTemple UniversityRan2023 to 2024Enrolled32ConditionsSchizophrenia Agitation, Schizo Affective Disorder, Bipolar Disorder, DexmedetomidineArmsDexmedetomidine, Lorazepam 2 MG/ML
3 · Its place in the literature

Who cites it

31 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Maria Rubio-ValeraFundació Sant Joan de Déu, Esplugues de Llobregat, Spain. mrubio@pssjd.org.
Juan V LucianoFundació Sant Joan de Déu, Esplugues de Llobregat, Spain. jvluciano@pssjd.org.
José Miguel OrtizParc Sanitari Sant Joan de Déu, Sant Boi de Llobregat, Spain. jmortiz@pssjd.org.
Luis Salvador-CarullaCentre for Disability Research and Policy, Faculty of Health Sciences, and Mental Health Policy Unit, Brain and Mind Research Institute, University of Sydney, Sydney, Australia. luis.salvador-carulla@sydney.edu.au.
Alfredo GraciaScientific Area, Ferrer, Barcelona, Spain. alfredogracia@ferrer.com.
Antoni Serrano-BlancoPrimary Care Prevention and Health Promotion Research Network (RedIAPP), Barcelona, Spain. aserrano@pssjd.org.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAgitation and containment are frequent in psychiatric care but little is known about their costs. The aim was to evaluate the use of services and costs related to agitation and containment of adult patients admitted to a psychiatric hospital or emergency service.

methodsSystematic searches of four electronic databases covering the period January 1998-January 2014 were conducted. Manual searches were also performed. Paper selection and data extraction were performed in duplicate. Cost data were converted to euros in 2014.

resultsTen studies met inclusion criteria and were included in the analysis (retrospective cohorts, prospective cohorts and cost-of-illness studies). Evaluated in these studies were length of stay, readmission rates and medication. Eight studies assessed the impact of agitation on the length of stay and six showed that it was associated with longer stays. Four studies examined the impact of agitation on readmission and a statistically significant increase in the probability of readmission of agitated patients was observed. Two studies evaluated medication. One study showed that the mean medication dose was higher in agitated patients and the other found higher costs of treatment compared with non-agitated patients in the unadjusted analysis. One study estimated the costs of conflict and containment incurred in acute inpatient psychiatric care in the UK. The estimation for the year 2014 of total annual cost per ward for all conflict was €182,616 and €267,069 for containment based on updated costs from 2005.

conclusionsAgitation has an effect on healthcare use and costs in terms of longer length of stay, more readmissions and higher drug use. Evidence is scarce and further research is needed to estimate the burden of agitation and containment from the perspective of hospitals and the healthcare system.

Indexed as

AggressionHealth Care CostsRestraint, PhysicalHospitalizationHumansMental Health ServicesPsychomotor Agitation

Identifiers

PMID25881240
PMCPMC4356166

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.